¿Por qué China no ha aprobado o desarrollado una vacuna de ARNm?news2022-02-18T21:19:19+00:00February 18th, 2022|The New York Times|
Why China Doesn’t Have an mRNA Vaccine for Covidnews2022-02-18T14:58:52+00:00February 18th, 2022|The New York Times|
¿Vacunar a los niños pequeños o esperar?news2022-02-11T18:08:17+00:00February 11th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
F.D.A. Approves Remdesivir for Patients Not Hospitalizednews2022-01-22T16:58:04+00:00January 22nd, 2022|The New York Times|
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boostersnews2021-12-31T02:43:34+00:00December 31st, 2021|The New York Times|
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Weeknews2021-11-17T01:17:59+00:00November 17th, 2021|The New York Times|
What Happens Next as F.D.A., C.D.C. Weigh Covid Shots for Childrennews2021-10-26T12:40:51+00:00October 26th, 2021|The New York Times|
F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11news2021-10-23T03:18:50+00:00October 23rd, 2021|The New York Times|
Pfizer Says Booster Shots of Its Vaccine Are Highly Protective Against Covidnews2021-10-22T00:45:33+00:00October 22nd, 2021|The New York Times|